A nurse is preparing to administer aspirin 81mg to a client who has atrial fibrillation. The nurse should explain that the purpose of this medication is which of the following.

Aspirin irreversibly inhibits platelet cyclooxygenase-1, reducing thromboxane A2 formation and platelet aggregation. Core concepts include platelet inhibition, thromboembolism prevention, antiplatelet therapy, and bleeding risk, particularly in conditions predisposing to clot formation such as atrial fibrillation. Rationale: A. Aspirin decreases platelet aggregation, lowering risk of thrombus formation and subsequent ischemic stroke in atrial fibrillation. Blood stasis in atria promotes clot formation, and antiplatelet therapy reduces embolization risk, particularly in clients with lower stroke risk profiles or contraindications to anticoagulants. B. Conversion to sinus rhythm requires antiarrhythmic agents or electrical cardioversion targeting cardiac conduction. Aspirin has no electrophysiologic effects on atrial activity or rhythm control, making it ineffective for restoring normal sinus rhythm in atrial fibrillation. C. Ventricular rate control is achieved with beta-blockers, calcium channel blockers, or digoxin affecting AV node conduction. Aspirin does not influence electrical impulse transmission or ventricular response rate, so it does not control heart rate in dysrhythmias. D. Clot dissolution requires thrombolytics such as alteplase that activate plasminogen for fibrinolysis. Aspirin only prevents platelet aggregation and does not break down existing clots, making it ineffective for actively dissolving thrombi in circulation.